Home > Boards > US OTC > Biotechs > Seneca Biopharma, Inc. (SNCA)

Breake-out! 2.20 printed.. :)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
leonardo1 Member Profile
 
Followed By 2
Posts 166
Boards Moderated 0
Alias Born 08/22/16
160x600 placeholder
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/20/2021 8:01:00 AM
Seneca Biopharma, Inc. Announces Top Line Data from Phase 2 Clinical Study in China for the Treatment of Ischemic Stroke PR Newswire (US) - 1/20/2021 8:00:00 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/13/2021 8:31:08 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/8/2021 9:00:46 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/8/2021 8:39:58 AM
Securities Registration: Business Combination (s-4) Edgar (US Regulatory) - 12/23/2020 5:04:28 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/21/2020 9:01:15 AM
Rowley Law PLLC is Investigating Proposed Acquisition of Seneca Biopharma, Inc. PR Newswire (US) - 12/18/2020 2:08:00 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/17/2020 7:03:59 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/17/2020 7:02:41 AM
Leading BioSciences and Seneca Biopharma Announce Merger PR Newswire (US) - 12/17/2020 7:00:00 AM
Seneca Biopharma Granted 180-Day Extension by NASDAQ to Regain Compliance with Bid Price Rule PR Newswire (US) - 12/15/2020 7:30:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 12/3/2020 5:28:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 5:02:18 PM
Seneca Biopharma Reports 2020 Third Quarter Results PR Newswire (US) - 11/10/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 6:06:44 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/28/2020 4:31:30 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/16/2020 5:01:17 PM
Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke PR Newswire (US) - 9/10/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2020 5:01:50 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/2/2020 2:29:54 PM
Letter from Seneca Biopharma's Executive Chairman PR Newswire (US) - 9/2/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/21/2020 4:45:49 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/20/2020 2:35:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2020 12:30:46 PM
leonardo1   Wednesday, 12/13/17 02:27:02 PM
Re: None
Post # of 4839 
Breake-out! 2.20 printed.. :)



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences